Annual CFI
-$17.92 M
-$13.11 M-272.50%
May 26, 2024
Summary
- As of February 7, 2025, LFCR annual cash flow from investing activities is -$17.92 million, with the most recent change of -$13.11 million (-272.50%) on May 26, 2024.
- During the last 3 years, LFCR annual CFI has fallen by -$5.61 million (-45.58%).
- LFCR annual CFI is now -122.41% below its all-time high of $79.96 million, reached on May 29, 2022.
Performance
LFCR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$2.47 M
+$922.00 K+27.18%
November 24, 2024
Summary
- As of February 7, 2025, LFCR quarterly cash flow from investing activities is -$2.47 million, with the most recent change of +$922.00 thousand (+27.18%) on November 24, 2024.
- Over the past year, LFCR quarterly CFI has increased by +$3.50 million (+58.62%).
- LFCR quarterly CFI is now -103.77% below its all-time high of $65.59 million, reached on February 1, 2022.
Performance
LFCR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$14.47 M
+$1.79 M+11.02%
November 24, 2024
Summary
- As of February 7, 2025, LFCR TTM cash flow from investing activities is -$14.47 million, with the most recent change of +$1.79 million (+11.02%) on November 24, 2024.
- Over the past year, LFCR TTM CFI has increased by +$6.98 million (+32.56%).
- LFCR TTM CFI is now -117.03% below its all-time high of $84.95 million, reached on February 1, 2022.
Performance
LFCR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LFCR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -272.5% | +58.6% | +32.6% |
| 3 y3 years | -45.6% | +58.6% | +32.6% |
| 5 y5 years | +81.5% | +58.6% | +39.1% |
LFCR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -122.4% | at low | -103.8% | +86.9% | -117.0% | +32.6% |
| 5 y | 5-year | -122.4% | +81.5% | -103.8% | +86.9% | -117.0% | +39.4% |
| alltime | all time | -122.4% | +81.5% | -103.8% | +96.7% | -117.0% | +86.3% |
Lifecore Biomedical Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | -$2.47 M(-27.2%) | -$14.47 M(-11.0%) |
| Aug 2024 | - | -$3.39 M(+28.6%) | -$16.26 M(-9.3%) |
| May 2024 | -$17.92 M(+272.5%) | -$2.64 M(-55.8%) | -$17.92 M(-16.5%) |
| Feb 2024 | - | -$5.97 M(+40.1%) | -$21.45 M(+113.4%) |
| Nov 2023 | - | -$4.26 M(-15.7%) | -$10.05 M(+4.3%) |
| Aug 2023 | - | -$5.05 M(-18.1%) | -$9.64 M(+100.4%) |
| May 2023 | -$4.81 M(-106.0%) | -$6.17 M(-213.6%) | -$4.81 M(-72.4%) |
| Feb 2023 | - | $5.43 M(-241.1%) | -$17.45 M(-140.8%) |
| Nov 2022 | - | -$3.85 M(+1602.7%) | $42.72 M(+3.0%) |
| Aug 2022 | - | -$226.00 K(-98.8%) | $41.47 M(-48.1%) |
| May 2022 | $79.96 M(-749.6%) | -$18.80 M(-128.7%) | $79.96 M(-5.9%) |
| Feb 2022 | - | $65.59 M(-1386.9%) | $84.95 M(+452.2%) |
| Nov 2021 | - | -$5.10 M(-113.3%) | $15.38 M(-40.2%) |
| Aug 2021 | - | $38.27 M(-377.1%) | $25.73 M(-309.0%) |
| May 2021 | -$12.31 M(-48.5%) | - | - |
| May 2021 | - | -$13.81 M(+247.4%) | -$12.31 M(+301.8%) |
| Feb 2021 | - | -$3.98 M(-175.8%) | -$3.06 M(+10.5%) |
| Nov 2020 | - | $5.25 M(+2161.2%) | -$2.77 M(-80.2%) |
| Aug 2020 | - | $232.00 K(-105.1%) | -$13.99 M(-41.4%) |
| May 2020 | -$23.89 M(-75.3%) | -$4.57 M(+23.9%) | -$23.89 M(+0.6%) |
| Feb 2020 | - | -$3.69 M(-38.3%) | -$23.75 M(-74.7%) |
| Nov 2019 | - | -$5.97 M(-38.2%) | -$94.04 M(+2.2%) |
| Aug 2019 | - | -$9.67 M(+118.5%) | -$92.03 M(-4.9%) |
| May 2019 | -$96.80 M(+172.0%) | -$4.42 M(-94.0%) | -$96.80 M(-8.0%) |
| Feb 2019 | - | -$73.98 M(+1771.6%) | -$105.22 M(+147.5%) |
| Nov 2018 | - | -$3.95 M(-72.6%) | -$42.52 M(-1.5%) |
| Aug 2018 | - | -$14.44 M(+12.4%) | -$43.16 M(+21.3%) |
| May 2018 | -$35.59 M(+40.0%) | -$12.84 M(+13.8%) | -$35.59 M(-8.2%) |
| Feb 2018 | - | -$11.28 M(+145.6%) | -$38.75 M(+20.5%) |
| Nov 2017 | - | -$4.59 M(-33.1%) | -$32.16 M(+6.6%) |
| Aug 2017 | - | -$6.87 M(-57.1%) | -$30.17 M(+18.7%) |
| May 2017 | -$25.42 M(-37.1%) | -$16.01 M(+241.3%) | -$25.42 M(+10.8%) |
| Feb 2017 | - | -$4.69 M(+80.2%) | -$22.95 M(-21.4%) |
| Nov 2016 | - | -$2.60 M(+22.6%) | -$29.18 M(-25.5%) |
| Aug 2016 | - | -$2.12 M(-84.3%) | -$39.14 M(-3.2%) |
| May 2016 | -$40.42 M(+17.4%) | -$13.54 M(+24.0%) | -$40.42 M(+18.7%) |
| Feb 2016 | - | -$10.92 M(-13.1%) | -$34.04 M(+34.7%) |
| Nov 2015 | - | -$12.57 M(+270.0%) | -$25.27 M(+11.1%) |
| Aug 2015 | - | -$3.40 M(-52.6%) | -$22.74 M(-34.0%) |
| May 2015 | -$34.44 M(+158.2%) | -$7.16 M(+233.8%) | -$34.44 M(+7.7%) |
| Feb 2015 | - | -$2.15 M(-78.6%) | -$31.97 M(-1.1%) |
| Nov 2014 | - | -$10.04 M(-33.5%) | -$32.34 M(+32.9%) |
| Aug 2014 | - | -$15.10 M(+221.6%) | -$24.34 M(+82.5%) |
| May 2014 | -$13.34 M(+28.0%) | -$4.69 M(+86.9%) | -$13.34 M(+24.2%) |
| Feb 2014 | - | -$2.51 M(+23.1%) | -$10.74 M(-5.1%) |
| Nov 2013 | - | -$2.04 M(-50.2%) | -$11.32 M(-3.5%) |
| Aug 2013 | - | -$4.10 M(+95.7%) | -$11.73 M(+12.6%) |
| May 2013 | -$10.42 M(-76.4%) | -$2.09 M(-32.2%) | -$10.42 M(-79.8%) |
| Feb 2013 | - | -$3.09 M(+25.9%) | -$51.54 M(+2.8%) |
| Nov 2012 | - | -$2.45 M(-11.9%) | -$50.16 M(+21.4%) |
| Aug 2012 | - | -$2.79 M(-93.6%) | -$41.31 M(-6.3%) |
| May 2012 | -$44.07 M(+50.0%) | -$43.21 M(+2429.9%) | -$44.07 M(-4686.2%) |
| Feb 2012 | - | -$1.71 M(-126.7%) | $961.00 K(-116.2%) |
| Nov 2011 | - | $6.39 M(-215.2%) | -$5.92 M(-53.7%) |
| Aug 2011 | - | -$5.55 M(-404.4%) | -$12.79 M(-56.5%) |
| May 2011 | -$29.39 M | $1.82 M(-121.2%) | -$29.39 M(-0.6%) |
| Feb 2011 | - | -$8.59 M(+1692.9%) | -$29.57 M(+55.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | -$479.00 K(-97.8%) | -$19.00 M(-7.9%) |
| Aug 2010 | - | -$22.14 M(-1451.8%) | -$20.63 M(-51.8%) |
| May 2010 | -$42.80 M(+246.9%) | $1.64 M(-17.5%) | -$42.80 M(-17.2%) |
| Feb 2010 | - | $1.99 M(-193.9%) | -$51.66 M(-1.1%) |
| Nov 2009 | - | -$2.11 M(-95.2%) | -$52.22 M(-3.6%) |
| Aug 2009 | - | -$44.31 M(+512.8%) | -$54.16 M(+339.0%) |
| May 2009 | -$12.34 M(-39.0%) | -$7.23 M(-605.6%) | -$12.34 M(-46.3%) |
| Feb 2009 | - | $1.43 M(-135.3%) | -$22.98 M(-9.4%) |
| Nov 2008 | - | -$4.05 M(+62.7%) | -$25.37 M(+13.0%) |
| Aug 2008 | - | -$2.49 M(-86.1%) | -$22.46 M(+11.1%) |
| May 2008 | -$20.21 M(-148.1%) | -$17.87 M(+1753.5%) | -$20.21 M(+615.0%) |
| Feb 2008 | - | -$964.00 K(-15.4%) | -$2.83 M(-106.1%) |
| Nov 2007 | - | -$1.14 M(+375.0%) | $46.23 M(+4.7%) |
| Aug 2007 | - | -$240.00 K(-50.3%) | $44.15 M(+5.0%) |
| May 2007 | $42.04 M(-865.9%) | -$483.00 K(-101.0%) | $42.04 M(+5.3%) |
| Feb 2007 | - | $48.09 M(-1591.7%) | $39.91 M(-597.9%) |
| Nov 2006 | - | -$3.22 M(+37.6%) | -$8.02 M(+29.3%) |
| Aug 2006 | - | -$2.34 M(-10.4%) | -$6.20 M(+12.9%) |
| May 2006 | -$5.49 M(+5.6%) | -$2.62 M(-1657.1%) | -$5.49 M(+10.3%) |
| Feb 2006 | - | $168.00 K(-111.9%) | -$4.98 M(-16.1%) |
| Nov 2005 | - | -$1.41 M(-13.8%) | -$5.93 M(+1.3%) |
| Aug 2005 | - | -$1.63 M(-22.3%) | -$5.86 M(+12.7%) |
| May 2005 | -$5.20 M(+681.4%) | -$2.10 M(+167.6%) | -$5.20 M(+97.6%) |
| Feb 2005 | - | -$786.00 K(-41.0%) | -$2.63 M(+59.2%) |
| Nov 2004 | - | -$1.33 M(+36.9%) | -$1.65 M(+12.1%) |
| Aug 2004 | - | -$974.00 K(-309.9%) | -$1.47 M(+121.5%) |
| May 2004 | -$665.00 K(-58.7%) | $464.00 K(+141.7%) | -$665.00 K(-75.3%) |
| Feb 2004 | - | $192.00 K(-116.6%) | -$2.69 M(-3.9%) |
| Nov 2003 | - | -$1.16 M(+595.8%) | -$2.80 M(-134.9%) |
| Aug 2003 | - | -$166.00 K(-89.4%) | $8.03 M(-7.7%) |
| May 2003 | -$1.61 M(-121.4%) | - | - |
| Apr 2003 | - | -$1.56 M(-1984.3%) | $8.70 M(+3.2%) |
| Jan 2003 | - | $83.00 K(-99.1%) | $8.43 M(+12.2%) |
| Oct 2002 | $7.52 M(-288.2%) | $9.68 M(+1808.7%) | $7.52 M(-423.9%) |
| Jul 2002 | - | $507.00 K(-127.6%) | -$2.32 M(-36.9%) |
| Apr 2002 | - | -$1.84 M(+120.9%) | -$3.68 M(-19.5%) |
| Jan 2002 | - | -$831.00 K(+416.1%) | -$4.57 M(+14.3%) |
| Oct 2001 | -$4.00 M(-72.2%) | -$161.00 K(-81.0%) | -$4.00 M(-21.4%) |
| Jul 2001 | - | -$848.00 K(-68.9%) | -$5.08 M(-3.6%) |
| Apr 2001 | - | -$2.73 M(+948.5%) | -$5.28 M(+1.1%) |
| Jan 2001 | - | -$260.00 K(-79.2%) | -$5.22 M(-63.7%) |
| Oct 2000 | -$14.36 M(>+9900.0%) | -$1.25 M(+20.5%) | -$14.36 M(+26.5%) |
| Jul 2000 | - | -$1.04 M(-61.1%) | -$11.35 M(-1.4%) |
| Apr 2000 | - | -$2.67 M(-71.6%) | -$11.51 M(+19.4%) |
| Jan 2000 | - | -$9.40 M(-633.8%) | -$9.64 M(>+9900.0%) |
| Oct 1999 | -$39.00 K(-101.0%) | $1.76 M(-246.7%) | -$39.00 K(-97.6%) |
| Jul 1999 | - | -$1.20 M(+50.0%) | -$1.60 M(-44.8%) |
| Apr 1999 | - | -$800.00 K(-500.0%) | -$2.90 M(+190.0%) |
| Jan 1999 | - | $200.00 K(0.0%) | -$1.00 M(-124.4%) |
| Oct 1998 | $4.10 M(-28.1%) | $200.00 K(-108.0%) | $4.10 M(+41.4%) |
| Jul 1998 | - | -$2.50 M(-327.3%) | $2.90 M(-77.3%) |
| Apr 1998 | - | $1.10 M(-79.2%) | $12.80 M(-4.5%) |
| Jan 1998 | - | $5.30 M(-630.0%) | $13.40 M(+135.1%) |
| Oct 1997 | $5.70 M(-127.5%) | -$1.00 M(-113.5%) | $5.70 M(-14.9%) |
| Jul 1997 | - | $7.40 M(+335.3%) | $6.70 M(-1057.1%) |
| Apr 1997 | - | $1.70 M(-170.8%) | -$700.00 K(-70.8%) |
| Jan 1997 | - | -$2.40 M | -$2.40 M |
| Oct 1996 | -$20.70 M | - | - |
FAQ
- What is Lifecore Biomedical annual cash flow from investing activities?
- What is the all time high annual CFI for Lifecore Biomedical?
- What is Lifecore Biomedical annual CFI year-on-year change?
- What is Lifecore Biomedical quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly CFI year-on-year change?
- What is Lifecore Biomedical TTM cash flow from investing activities?
- What is the all time high TTM CFI for Lifecore Biomedical?
- What is Lifecore Biomedical TTM CFI year-on-year change?
What is Lifecore Biomedical annual cash flow from investing activities?
The current annual CFI of LFCR is -$17.92 M
What is the all time high annual CFI for Lifecore Biomedical?
Lifecore Biomedical all-time high annual cash flow from investing activities is $79.96 M
What is Lifecore Biomedical annual CFI year-on-year change?
Over the past year, LFCR annual cash flow from investing activities has changed by -$13.11 M (-272.50%)
What is Lifecore Biomedical quarterly cash flow from investing activities?
The current quarterly CFI of LFCR is -$2.47 M
What is the all time high quarterly CFI for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly cash flow from investing activities is $65.59 M
What is Lifecore Biomedical quarterly CFI year-on-year change?
Over the past year, LFCR quarterly cash flow from investing activities has changed by +$3.50 M (+58.62%)
What is Lifecore Biomedical TTM cash flow from investing activities?
The current TTM CFI of LFCR is -$14.47 M
What is the all time high TTM CFI for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM cash flow from investing activities is $84.95 M
What is Lifecore Biomedical TTM CFI year-on-year change?
Over the past year, LFCR TTM cash flow from investing activities has changed by +$6.98 M (+32.56%)